Putting The Spotlight On Quince Therapeutics Inc (QNCX)

Quince Therapeutics Inc (NASDAQ:QNCX) currently has a daily average trading volume of 489.29K but it saw 2179058 shares traded in last market. With a market cap of 70.11M USD, the company’s current market price of $1.62 came rising about 23.66 while comparing to the previous closing price of $1.31. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.79 and as low as $0.51. In the recent trading on the day, stock has struck highest price mark of $1.24 while lowest mark touched by it was $1.69.

Taking a look at 20-day trading activity of Quince Therapeutics Inc (QNCX) gives us an average price of $0.9124, while its current price level is -9.50% below from 52-week high level whereas it is 216.65% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8042 while that of 200 days or SMA-200 reads an average of $0.9287. A closer look into the stock’s movement over the week reveals that its volatility is standing at 28.56% during that period while stretching the period over a month that decreases to 15.79%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 80.09 which implies that the stock is in overbought territory.

Over the week, QNCX’s stock price is moving 36.13% up while it is 109.03% when we observe its performance for the past one month. Year-to-date it is 54.29% up and over the past year, the stock is showing an upside performance of 66.91%.

The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of -0.1 while estimate for next year EPS is -1.14.

Currently, Quince Therapeutics Inc’s total number of outstanding shares is 42.97M. Company’s return on investment (ROI) stands at -86.72% and return on equity (ROE) at -79.38%. Stock’s beta reads 0.85. Stock has a price to book (P/B) ratio of 1.49. Its return on asset (ROA) is -47.50% on average.